scorecard

You Searched For "covifor" and got 20 results


Sort By:


Business Insider Latest Story Image
1 min read

Generic COVID-19 drug priced at ₹5,400 per vial by Hyderabad-based Hetero

They will be made available in two equal lots of 10,000 each. One lot will be immediately supp…

Business Insider Latest Story Image
1 min read

Fabiflu, Covifor, Cipremi and other drugs approved or under trial for COVID-19 patients in India

There is some good news for Indians — medicines showing promising results to treat coronavirus. Ind…

Preeti Soni   


Business Insider Latest Story Image
2 mins read

Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across India

"The launch of Covifor in India is a significant milestone for all of us... Through Covifor, we ho…

PTI   


Business Insider Latest Story Image
1 min read

Hetero to supply 60,000 vials of generic Remdesvir from July 13

Remdesivir is the only drug approved by the United States Food and Drug Administration (USFDA) for …

PTI   


Business Insider Latest Story Image
1 min read

Hetero gets DCGI nod to launch COVID-19 drug

"Backed by strong backward integration capabilities, we can ensure that the product is immediately…

PTI   


Business Insider Latest Story Image
1 min read

Hetero Healthcare Ltd starts supply of generic Remdesivir

Remdesivir is the only drug approved by the United States Food and Drug Administration (USFDA) for …

PTI   


Business Insider Latest Story Image
3 mins read

These are the companies that are making Remdesivir in India

Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…

Business Insider Latest Story Image
2 mins read

These are the companies that are making Remdesivir in India

Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…

Business Insider Latest Story Image
1 min read

Itolizumab approved for emergency use on COVID-19 patients

"The approval was given after its clinical trials on COVID-19 patients in India was found sati…

PTI   


Business Insider Latest Story Image
1 min read

New regulation for faster vaccines and treatments for COVID-19 adopted by EU

Members of the European Parliament (MEPs) have adopted a new regulation that will allow vaccines an…

Business Insider Latest Story Image
4 mins read

Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients

The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…

Business Insider Latest Story Image
2 mins read

What’s allowed and what isn’t as Madurai lockdown tightens for the next one week

Tamil Nadu government has enforced a seven days long complete lockdown in Madurai as the coronaviru…

Business Insider Latest Story Image
3 mins read

₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500⁠— here’s why

Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…

Business Insider Latest Story Image
6 mins read

Inside the treacherous black market for Remdesivir in India— from private hospitals to distributors

The black market for drugs that could treat COVID-19 is surging in India, especially when it comes …

Business Insider Latest Story Image
5 mins read

Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study

Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…

Business Insider Latest Story Image
3 mins read

Remdesivir, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts

Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…

PTI   


Business Insider Latest Story Image
3 mins read

Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts

Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…

PTI   


Business Insider Latest Story Image
4 mins read

India's COVID-19 tally crosses 4 lakh with highest single-day spike of 15,413 cases, fresh concerns over rapid rise

The first "Sunday shutdown" during the 'Unlock' phase with an exception only for hospitals and all…

PTI   


Business Insider Latest Story Image
5 mins read

After death count, Delhi now in 2nd spot in COVID-19 caseload too; Goa reports 1st fatality from the disease

As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre mai…

PTI   


Business Insider Latest Story Image
5 mins read

Goa reports 1st COVID-19 fatality as death toll jumps by a record 445, Delhi surpasses TN to be in 2nd spot

Glenmark Pharmaceuticals has launched the antiviral drug Favipiravir, under the brand name FabiFlu…

PTI